Pharmaceutical Formulation for Regulating the Timed Release of Biologically Active Compounds Based on a Polymer Matrix
A formulation containing a biologically active compound having a structure with hydrogen bonding sites is blended with a polymer having a structure with complementary hydrogen bonding sites, the polymer forming hydrolytic degradation products that promote the release of the biologically active compound from the polymer.
Patents:US 20,090,285,895
Inventor(s):
KOHN JOACHIM B [US]; SCHACHTER DEBORAH M [US]
Type of Offer:
Licensing
« More Pharmaceutical Patents